HUP9702244A3 - Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders - Google Patents
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disordersInfo
- Publication number
- HUP9702244A3 HUP9702244A3 HU9702244A HU9702244A HUP9702244A3 HU P9702244 A3 HUP9702244 A3 HU P9702244A3 HU 9702244 A HU9702244 A HU 9702244A HU 9702244 A HU9702244 A HU 9702244A HU P9702244 A3 HUP9702244 A3 HU P9702244A3
- Authority
- HU
- Hungary
- Prior art keywords
- prophylaxis
- manufacture
- treatment
- pharmaceutical composition
- gynaecological disorders
- Prior art date
Links
- 239000004305 biphenyl Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK4695 | 1995-01-13 | ||
DK4895 | 1995-01-13 | ||
DK4595 | 1995-01-13 | ||
DK4795 | 1995-01-13 | ||
DK4495 | 1995-01-13 | ||
DK77095 | 1995-06-30 | ||
DK76995 | 1995-06-30 | ||
DK77295 | 1995-06-30 | ||
DK76895 | 1995-06-30 | ||
DK77195 | 1995-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9877967A2 HUP9877967A2 (en) | 1998-12-28 |
HUP9702244A3 true HUP9702244A3 (en) | 1999-12-28 |
Family
ID=27579214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702244A HUP9702244A3 (en) | 1995-01-13 | 1995-01-10 | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0804190A1 (no) |
JP (1) | JPH10511962A (no) |
CN (1) | CN1168096A (no) |
AU (1) | AU693628B2 (no) |
CA (1) | CA2208861A1 (no) |
CZ (1) | CZ212297A3 (no) |
HU (1) | HUP9702244A3 (no) |
IL (1) | IL116746A0 (no) |
MX (1) | MX9705219A (no) |
NO (1) | NO973243L (no) |
WO (1) | WO1996021444A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69718500T2 (de) * | 1996-10-28 | 2003-11-27 | Novo Nordisk As | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen |
US6316494B1 (en) | 1996-10-28 | 2001-11-13 | Novo Nordisk A/S | cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
IL129618A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
WO1998018772A1 (en) * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
IL129616A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
EP0937058A1 (en) * | 1996-10-28 | 1999-08-25 | Novo Nordisk A/S | NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
IL129617A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US5958967A (en) * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
JP2001502706A (ja) * | 1996-10-28 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―3,4クロマン誘導体 |
ZA979644B (en) * | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. |
US5994390A (en) * | 1996-10-28 | 1999-11-30 | Novo Nordisk | Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US6043269A (en) * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
IL129627A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US5919817A (en) * | 1996-10-28 | 1999-07-06 | Novo Nordisk A/S | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US7214706B2 (en) | 2000-03-01 | 2007-05-08 | Akzo Nobel N.V. | Chroman derivatives as estrogenic compounds |
WO2006032085A1 (en) | 2004-09-21 | 2006-03-30 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
WO2012061413A2 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
ES2643407T3 (es) | 2014-02-07 | 2017-11-22 | Novogen Ltd. | Compuestos de benzopirano funcionalizados y uso de los mismos |
ES2877712T3 (es) | 2015-02-02 | 2021-11-17 | Mei Pharma Inc | Terapias combinadas para su uso en el tratamiento del cáncer de mama |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
-
1995
- 1995-01-10 HU HU9702244A patent/HUP9702244A3/hu unknown
-
1996
- 1996-01-10 WO PCT/DK1996/000015 patent/WO1996021444A1/en not_active Application Discontinuation
- 1996-01-10 JP JP8521378A patent/JPH10511962A/ja active Pending
- 1996-01-10 MX MX9705219A patent/MX9705219A/es unknown
- 1996-01-10 EP EP96900096A patent/EP0804190A1/en not_active Withdrawn
- 1996-01-10 CN CN96191414A patent/CN1168096A/zh active Pending
- 1996-01-10 CA CA002208861A patent/CA2208861A1/en not_active Abandoned
- 1996-01-10 AU AU43293/96A patent/AU693628B2/en not_active Ceased
- 1996-01-10 CZ CZ972122A patent/CZ212297A3/cs unknown
- 1996-01-12 IL IL11674696A patent/IL116746A0/xx unknown
-
1997
- 1997-07-11 NO NO973243A patent/NO973243L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2208861A1 (en) | 1996-07-18 |
IL116746A0 (en) | 1996-05-14 |
JPH10511962A (ja) | 1998-11-17 |
MX9705219A (es) | 1997-10-31 |
WO1996021444A1 (en) | 1996-07-18 |
NO973243D0 (no) | 1997-07-11 |
NO973243L (no) | 1997-07-11 |
AU693628B2 (en) | 1998-07-02 |
HUP9877967A2 (en) | 1998-12-28 |
EP0804190A1 (en) | 1997-11-05 |
CZ212297A3 (en) | 1997-11-12 |
AU4329396A (en) | 1996-07-31 |
CN1168096A (zh) | 1997-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9702244A3 (en) | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders | |
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
HK1008180A1 (en) | Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism | |
AU4060599A (en) | Pharmaceutical composition for treating or preventing sleep disorders | |
HUP9902683A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms | |
AU1367397A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes | |
PL322526A1 (en) | Azathiopyrin compositions for intracolic administration | |
HUP9702246A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders | |
HUP9800334A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity | |
IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
HK1017684A1 (en) | Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases | |
CA2260863A1 (en) | Treatment of psychotic disorders | |
AU5627796A (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
AU4329196A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | |
HUP9800133A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia | |
AU686084B3 (en) | Pharmaceutical compositions for the treatment of depressive disorders | |
ZA98682B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders | |
ZA96439B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders | |
ZA96446B (en) | Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity | |
ZA96440B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | |
ZA97168B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of prostatic carcinoma | |
ZA97170B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms. | |
ZA96248B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia | |
AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
IL126276A0 (en) | The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system |